Introduction: Laryngeal tuberculosis (LTB) accounts for less than 1% of all tuberculosis cases. Its diagnosis is complex due to its non-specific clinical manifestations in the larynx. Case presentation: A 78-year-old man presented to the emergency room of a hospital in Bogotá D.C. (Colombia) with exertional dyspnea, dry cough, dysphonia, odynophagia, and dysphagia over the last 3 months, with worsening of respiratory symptoms in the last 24 hours. Admission laboratory tests showed an elevated D-dimer level; therefore, due to suspected pulmonary thromboembolism, a contrast-enhanced CT chest angiography was performed. No signs of thromboembolism were observed, but centrilobular lung micronodules, a tree-in-bud pattern, and changes related to previous pulmonary fibrosis were observed. Due to the risk of aspiration, a nasopharyngoscopy was performed, finding leukoplakia on the right ventricular fold and the right vocal fold. Based on these findings, a biopsy of the lesions, acid-fast bacilli (AFB) staining, and a PCR test for Mycobacterium tuberculosis were requested, all of which were positive. Antituberculosis therapy (RHZE 150/75/400/275 mg) was initiated 5 days after diagnosis once his condition was stabilized; the biopsy was postponed for the same reason. Given the favorable response, he was discharged 4 days after starting treatment. A follow-up nasolaryngoscopy at 30 days showed a significant reduction in the pseudotumoral lesions on the ventricular fold and complete resolution on the vocal fold. At the 3-month follow-up, respiratory symptoms had improved considerably. Conclusion: Although it is a very rare condition, LTB should be considered as a differential diagnosis in patients with non-specific symptoms (such as dysphonia, dysphagia, and odynophagia) and laryngeal lesions, even in countries without a high TB burden like Colombia. Timely initiation of anti-tuberculosis therapy is essential to prevent serious complications, given the excellent and rapid response to this treatment.